InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: CJR_MS post# 41389

Monday, 01/26/2015 5:27:46 PM

Monday, January 26, 2015 5:27:46 PM

Post# of 423549
C-

Never good to lose any time, but it isn't significant. Yes, they could make more revenue - not billions - w ANCHOR as ONE OF the add-on drug, but not as THE add-on drug (with R-IT).

The overall picture had not been changed during the last 2 years. If R-IT will be successful and patents will hold: it will change the life of 'everybody'. If any of these will fail (low eff. or invalid) V will be one of the available drug.

If ANCHOR was approved it would makes easier to reach the finish line - it is more difficult now, but not impossible. To stop R-IT wasn't an option ever - it is the 'mission statement'.

Best,
HDG
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News